Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
patients are hard to get back for their second dose; This non-serious case was reported by a physician via sales rep and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received 1st dose of vaccine on an unknown date). On an unknown date, the patients did not receive the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: patients are hard to get back for their second dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-JUN-2025 The field representative reported the question from a pediatrician who wanted to know what the efficacy after just one dose was of Bexsero. She was asking this because multiple patients were hard to get back for their second dose and she was just curious about what efficacy would give just one dose. This AE (adverse event) was filed as potential since the reporter stated that the pediatrician said that it was hard to get back the patients to complete their schedules. So, more than one patient could be involved. Till the time of reporting, the patient did not receive 2nd dose of Bexsero, which led to an incomplete course of vaccination.